LOXL1-AS1 and thymic carcinoma: Therefore, the overexpression of HSPA9, resulting from the overexpression of LOXL1AS1, inhibits apoptosis and promotes proliferation and invasion in both thymoma and thymic carcinoma (Figure 6).